3D Orthobiologic Solutions
Overview
3D Orthobiologic Solutions (3DOS) is a medical technology company specializing in the development of customizable, 3D-printed scaffolds for use in orthobiological applications, particularly focusing on oral and maxillofacial surgery. Founded in 2019, the company is based in Herndon, Virginia. It was co-founded by Dr. R. Prakash Kolli, an engineer with extensive expertise in medical technology. The company is actively involved in developing scaffolds using biocompatible materials optimized for bone regrowth, aiming to provide cost-effective and high-quality solutions in the medical device industry.
Recent Developments
- October 2024: 3D Orthobiologic Solutions presented at the Accelerate Investor Conference in Arlington, Virginia. Dr. Kolli, the CEO and co-founder, participated in The Big Launch Challenge pitch competition.
- August 2024: Jeff Eardley joined as Director of Growth, bringing expertise in medical device commercialization to 3DOS.
- June 2024: 3DOS was selected to participate in the MassChallenge U.S. Early Stage Cohort, being one of 128 startups chosen from over 1,300 applicants.
- March 2024: 3DOS received a grant of $20,000 funded by Lighthouse Labs RVA.
- 2023: The company acquired Blue Point Materials Research, LLC along with its antibacterial stainless steel technology, enhancing its portfolio.
- 2023: Dr. Leslie Barnes Remski joined the company's medical advisory board, contributing her expertise as a board-certified orthopedic trauma surgeon.
Company Information
| Attribute | Information |
|---|---|
| Founding Date | 2019 |
| Headquarters | Herndon, Virginia |
| Founders | Dr. R. Prakash Kolli |
| Revenue | Not publicly disclosed |
| Profits | Not publicly disclosed |
| Key Investors | Lighthouse Labs RVA |
| Industry | Medical Device |
| Number of Employees | 2-10 |
Early History
3D Orthobiologic Solutions was founded in 2019 with a focus on addressing the challenges in oral and maxillofacial surgery. The company recognized the limitations of current bone repair techniques in oral surgery, which often involved expensive and time-consuming procedures using autografts or allografts. Founders like Dr. R. Prakash Kolli endeavored to innovate a solution that would reduce these barriers, emphasizing the use of 3D-printed scaffolds that are customizable and biocompatible. Early on, 3DOS committed to leveraging biomaterials to promote efficient bone regrowth, thereby offering a new avenue for restorative dental procedures.
Company Profile and Achievements
3D Orthobiologic Solutions operates within the medical device industry, focusing on the development of scaffolds that aid in bone regeneration for oral surgeries. These scaffolds are designed to be used in cases of segmental bone defects that typically result from cancer, trauma, or infection:
- Development of 3D-printed Scaffolds: 3DOS has engineered scaffolds that match defect geometries precisely, which decreases both the cost and recovery time associated with conventional surgery techniques.
- Cost Reduction Strategies: The company's technology aims to slash costs by up to 50%, reducing the need for traditional bone grafts and allowing for faster operations.
- Innovative Projects: The participation in elite startup cohorts like the MassChallenge reflects its innovative standing in the startup ecosystem.
Current Operations and Market Position
Currently, 3D Orthobiologic Solutions is actively developing, marketing, and refining its bone regeneration scaffolds. The market position of 3DOS is underpinned by its emphasis on bringing cost-effective and advanced solutions for bone regeneration, primarily aiding oral and maxillofacial surgeries. It operates privately, supported by a relatively small team, and its technological solutions provide it with competitive advantages by enabling a reduction in surgery times and costs. Moreover, being part of various innovation competitions signifies its growing reputation within the regenerative medicine technology sector.
Conclusion
3D Orthobiologic Solutions is at the forefront of leveraging 3D printing technologies in healthcare, aiming to refine and innovate surgical solutions in the medical device industry. Through focused R&D and a dedication to reducing costs and enhancing recovery times, the company is positioned to be a significant player in the niche of regenerative medical technologies. Moving forward, its continued participation in prestigious accelerator programs and competitions is likely to drive further growth and recognition within the medical technology field.